Editor’s Note Archive

Pharma regulations: Awaiting an elixir?

Read more

Wooing Indian pharma back

Read more

Standing up to Big Brother

Read more

Learnings from the Ranbaxy saga

Read more

Coming clean for World Environment Day

Read more

Needed: A renaissance in clinical research

Read more

A paucity of perception

Read more

From Glivec to Januvia and the Indo-EU FTA

Read more

‘Copiers’ but saviours nonetheless …

Read more

Terminating TB’’s terror

Read more